You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 139 No. 9, September 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Study
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on Web of Science (14)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Head & Neck Cancer
 •Otolaryngology/ Head & Neck Surgery
 •Dermatologic Disorders
 •Radiologic Imaging
 •PET/ SPECT Imaging
 •Dermatologic Disorders, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?


Positron Emission Tomography for Basal Cell Carcinoma of the Head and Neck

Scott W. Fosko, MD; Weimin Hu, MD, PhD; Thomas F. Cook, MD; Val J. Lowe, MD

Arch Dermatol. 2003;139:1141-1146.

Objective  To determine the ability of fluorodeoxyglucose F 18 positron emission tomography (FDG-PET) to image basal cell carcinoma (BCC).

Design  Case series study.

Setting  Mohs surgery practice in a tertiary university hospital.

Patients  Six patients with BCC larger than 1.0 cm of the head and neck region were identified.

Results  Patients were imaged using FDG-PET before surgery. In 3 patients, PET imaging correlated well with the size and extent of the soft tissue invasion. Histologically, all 3 tumors were of the nodular subtype. The remaining 3 patients failed to demonstrate identifiable tumor activity on PET. Two of these 3 tumors were of the infiltrative histologic subtype, and 1 was of the nodular subtype. Perineural spread was detected by tissue biopsy in 1 infiltrative tumor, but not by FDG-PET imaging.

Conclusions  In our study, FDG-PET imaging was able to image and identify BCC in the head and neck region in 3 of 6 patients. In some cases, anatomic accuracy and the extent of soft tissue invasion were observed. The histologic subtype of the BCC appears to affect the ability of FDG-PET detection, with the nodular histologic subtype more likely to test positive on PET. This is a preliminary study, and future investigation is needed to evaluate the role of PET imaging in the management of patients with BCC.


From the Department of Dermatology, Saint Louis University Health Sciences Center (Drs Fosko and Cook), and Saint Louis University School of Medicine (Dr Hu), St Louis, Mo; and Department of Radiology, Mayo Clinic, Rochester, Minn (Dr Lowe). Dr Hu is now with the Department of Dermatology, Case Western Reserve University, Cleveland, Ohio. Dr Cook is now in private practice in Visalia, Calif. The authors have no relevant financial interest in this article.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.